financetom
Business
financetom
/
Business
/
BRIEF-Allovir And Kalaris Therapeutics Announce Merger To Form Company Focused On Retinal Diseases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Allovir And Kalaris Therapeutics Announce Merger To Form Company Focused On Retinal Diseases
Nov 8, 2024 3:40 AM

Nov 8 (Reuters) - Allovir Inc ( ALVR ):

* ALLOVIR AND KALARIS THERAPEUTICS ANNOUNCE AGREEMENT FOR

TRANSFORMATIONAL MERGER TO CREATE COMPANY FOCUSED ON DISEASES OF

THE RETINA

* ALLOVIR INC ( ALVR ) - TO ACQUIRE 100% OF KALARIS EQUITY INTEREST

* ALLOVIR INC ( ALVR ) - STOCKHOLDERS TO OWN 25.05% OF COMBINED

COMPANY

POST-MERGER

* ALLOVIR INC ( ALVR ) - COMBINED COMPANY TO BE LED BY KALARIS CEO

ANDREW

OXTOBY

* ALLOVIR INC ( ALVR ) - COMBINED COMPANY TO OPERATE AS KALARIS

THERAPEUTICS, INC. AND TRADE AS KLRS

* ALLOVIR INC ( ALVR ) - TH103 PHASE 1 CLINICAL TRIAL DATA EXPECTED

IN Q3

2025

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Safe Pro Group Inc Says Now Expects IPO Price Will Be Between $4.25 And $5.75 Per Share - SEC Filing
BRIEF-Safe Pro Group Inc Says Now Expects IPO Price Will Be Between $4.25 And $5.75 Per Share - SEC Filing
Jul 19, 2024
July 19 (Reuters) - * SAFE PRO GROUP INC SAYS NOW EXPECTS IPO PRICE WILL BE BETWEEN $4.25 AND $5.75 PER SHARE - SEC FILING * SAFE PRO GROUP INC SAYS IT HAD PREVIOUSLY EXPECTED IPO PRICE TO BE BETWEEN $4.00 AND $6.00 PER SHARE Source text for Eikon: ...
BRIEF-Fatpipe Files For IPO - SEC Filing
BRIEF-Fatpipe Files For IPO - SEC Filing
Jul 19, 2024
July 19 (Reuters) - * FATPIPE FILES FOR IPO - SEC FILING * FATPIP: INTEND TO HAVE STOCK LISTED ON NASDAQ UNDER SYMBOL FATN Source text for Eikon: ...
Oracle CEO Safra Catz to depart Walt Disney board
Oracle CEO Safra Catz to depart Walt Disney board
Jul 19, 2024
July 19 (Reuters) - Walt Disney ( DIS ) said on Friday that Oracle chief executive Safra Catz is departing the entertainment company's board after six years. Catz was elected to Disney's ( DIS ) board in 2017 along with Illumina Inc's ( ILMN ) former CEO Francis deSouza, at a time when the company was looking to acquire Twenty-First...
Immunovant Insider Sold Shares Worth $257,888, According to a Recent SEC Filing
Immunovant Insider Sold Shares Worth $257,888, According to a Recent SEC Filing
Jul 19, 2024
05:41 PM EDT, 07/19/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on July 17, 2024, sold 8,685 shares in Immunovant ( IMVT ) for $257,888. Following the Form 4 filing with the SEC, Salzmann has control over a total of 1,023,412 shares of the company, with 1,023,412 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1764013/000176401324000133/xslF345X03/wk-form4_1721424975.xml Price: 28.00, Change: +0.03, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved